Scimago Lab
powered by Scopus
Formerly the IP & Science
business of Thomson Reuters


eISSN: 1643-3750

Get your full text copy in PDF

Course of viral hepatitis B and combined B and C hepatitis in children treated for neoplastic diseases.

Robert Debski, Jan Styczyński, Mariusz Wysocki, Sylwia Kołtan, Violetta Swiatkiewicz, Andrzej Kołtan, Anna Balcar-Boroń

Med Sci Monit 2002; 8(4): CR274-279

ID: 420868

BACKGROUND: Viral hepatitis C in children is milder than in adults. Patientswith tumors, because of immune deficits, seem to be at risk of rapid liver disease progression. Littleis known about the course of HCV and dual HBV-HCV infections in such patients. MATERIAL/METHODS: Thestudy assessed clinical courses of HCV and dual HBV-HCV infections in 249 children with tumors aged 1-18years, divided into four groups: with HCV infection - 53, HBV-HCV infection - 53, HBV only - 33 and infection-free- 110. RESULTS: Hepatitis C was often chronic - in 83.3% of patients with HCV and 77.3% of those withdual infection. Over 80% had no jaundice. Mean AlAT activity was the highest in the HCV group (149.2I202.7IU/l), lower in the dual infection group (123.3I148.1 IU/l; p<0.02), and the lowest in HBV (92.7±152.9 IU/l). Transaminasemia course in patients with HCV and dual HBV-HCV infections was most frequently fluctuating (50.9% and 45.3%, respectively). 52.8% of children with HCV demonstrated no advanced inflammatory lesions with invasion of the
lamina limitans, no marked fibrosis, and minimum changes in descriptive classification. In 92.3% of children with dual infections, inflammatory activity was mild or mean, with no fibrosis
in 61.5%, and persistent chronic inflammation predominant in descriptive classification(46.1%).
Conclusions: HCV and HBV-HCV infections in children with neoplastic diseases tend to take chronic forms, but their clinical course is mild with signs of severe inflammatory activity or hepatic
stroma remodeling observed on histopathology.

This paper has been published under Creative Common Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) allowing to download articles and share them with others as long as they credit the authors and the publisher, but without permission to change them in any way or use them commercially.
I agree